 Home > Medical News > Latest Medical News > Introduce two new gout drug projects, Tonghua Dongbao and WuXi AppTec have reached a cooperation

Introduce two new gout drug projects, Tonghua Dongbao and WuXi AppTec have reached a cooperation

 Last Update: 2021-08-09
 Source: Internet
 Author: User

Tags

uric acid formula

heat treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 30, Tonghua Dongbao announced that its subsidiary Dongbao Zixing and WuXi AppTec signed two Class 1 new drug technology transfer contracts for the treatment of gout (hyperuricemia), and obtained THDB130/THDB131 and THDB150/ THDB151 has the global intellectual property rights and related interests of the products of the two projects, and is responsible for the follow-up clinical development, production and commercialization activities of the products of this project according to the agreement between the two parties

In this cooperation, Dongbao will pay WuXi AppTec two patent transfer fees and IND development stage technology transfer fees totaling RMB 70 million.

Currently, THDB130/THDB131 has been completed by WuXi AppTec for pre-clinical research and development activities.

In recent years, China's hyperuricemia has shown a significant increase and a younger trend

The introduction of THDB130/THDB131 by Tonghua Dongbao is expected to provide a safer and more effective treatment plan for patients with gout; and THDB150/THDB151 can inhibit xanthine oxidase and reduce the production of uric acid from the source because of its special advantages in mechanism.

Dongbao Zixing is a wholly-owned subsidiary of Tonghua Dongbao.

Since its establishment, Dongbao has accelerated the introduction and development of innovative drugs.

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.